You are here

Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus.

TitleExpression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus.
Publication TypeJournal Article
Year of Publication2003
AuthorsUeti, MW, Palmer, GH, Kappmeyer, LS, Scoles, GA, Knowles, DP
JournalJ Clin Microbiol
Volume41
Issue12
Pagination5803-9
Date Published2003 Dec
ISSN0095-1137
KeywordsAnimals, Antigens, Protozoan, Babesia, Digestive System, Epithelial Cells, Humans, Insect Vectors, Ixodidae, Membrane Proteins, Polymerase Chain Reaction, Protozoan Proteins, Salivary Glands
Abstract

Equi merozoite antigens 1 and 2 (EMA-1 and EMA-2) are Babesia equi proteins expressed on the parasite surface during infection in horses and are orthologues of proteins in Theileria spp., which are also tick-transmitted protozoal pathogens. We determined in this study whether EMA-1 and EMA-2 were expressed within the vector tick Boophilus microplus. B. equi transitions through multiple, morphologically distinct stages, including sexual stages, and these transitions culminate in the formation of infectious sporozoites in the tick salivary gland. EMA-2-positive B. equi stages in the midgut lumen and midgut epithelial cells of Boophilus microplus nymphs were identified by reactivity with monoclonal antibody 36/253.21. This monoclonal antibody also recognized B. equi in salivary glands of adult Boophilus microplus. In addition, quantification of B. equi in the mammalian host and vector tick indicated that the duration of tick feeding and parasitemia levels affected the percentage of nymphs that contained morphologically distinct B. equi organisms in the midgut. In contrast, there was no conclusive evidence that B. equi EMA-1 was expressed in either the Boophilus microplus midgut or salivary gland when monoclonal antibody 36/18.57 was used. The expression of B. equi EMA-2 in Boophilus microplus provides a marker for detecting the various development stages and facilitates the identification of novel stage-specific Babesia proteins for testing transmission-blocking immunity.

Alternate JournalJ. Clin. Microbiol.
PubMed ID14662988
PubMed Central IDPMC308990